Chemours (CC) EBT Margin (2014 - 2026)

Chemours' EBT Margin history runs 13 years deep, the most recent figure standing at 1.59% for Q1 2026.

• On a quarterly basis, EBT Margin changed N/A year-over-year to 1.59% in Q1 2026; TTM through Mar 2026 was 5.14%, a 579.0% decrease from a year earlier, with the FY2025 full-year figure at 7.8%, down 403.0% from the prior year.
• EBT Margin climbed to 1.59% in Q1 2026 per CC's latest filing, from 5.04% in the prior quarter.
• Across five years, EBT Margin topped out at 16.83% in Q3 2022 and bottomed at 26.08% in Q2 2023.
• The 5-year median for EBT Margin is 0.47% (2023), against an average of 0.53%.
• Across the five-year window, EBT Margin tumbled 3815 bps in 2023 and surged 3052 bps in 2024, its largest moves.
• Year by year, EBT Margin stood at 5.16% in 2022, then decreased by 1 bps to 5.19% in 2023, then soared by 101 bps to 0.07% in 2024, then plunged by 6951 bps to 5.04% in 2025, then jumped by 68 bps to 1.59% in 2026.
• Per Business Quant, the three latest CC EBT Margin figures stand at 1.59% (Q1 2026), 5.04% (Q4 2025), and 2.54% (Q3 2025).